Möchten Sie immer auf dem neuesten Stand bleiben?

OSLO, NORWAY and METUCHEN, NJ (August 18th, 2015) – Nattopharma proudly announces that another important study utilizing its MenaQ7® Vitamin K2 as MK-7 as the source material, has been published in...

OSLO, NORWAY and METUCHEN, NJ (August 14, 2015) – Nattopharma proudly announces its sponsorship of the Vitamin K2 Workshop that has been added to the education agenda for this year’s SupplySide West...

NattoPharma and TG Montgomery, one of the largest sales agents of vitamin K2 in Norway, have signed an agreement to enter the Swedish market with the brand MenaQ7® - K2 vitamin. TG Montgomery is one...

Christopher von Schirach-Szmigiel was elected as member of the Board of Directors in NattoPharma ASA for a period of two years at the General Assembly 25th June 2015.  Frode Marc Bohan remains...

Please find enclosed the Minutes of Annual General Meeting 2015, NattoPharma ASA...

The Board of Directors of NattoPharma ASA (the “Company”) hereby convenes an Annual General Meeting 25 June 2015 at 15:00 hours (CET) at the Company's office in Kirkeveien 59B, 1363 Høvik. Please see...

Please find enclosed corrected 1st Quarter 2015 Report for NattoPharma ASA. On page 3, "Key Financials" the EBITDA has been incorrectly stated for both 2015 and 2014. This has now been updated....

Please find enclosed presentation of 1st Quarter 2015 results from NattoPharma ASA held at KS Agenda Conference Center, Oslo May 29th 2015....

Please find enclosed NattoPharma ASA 1st Quarter 2015 Report For further information, please contact Hogne Vik CEO Phone: +47 97 53 53 26 e-mail: hogne.vik@nattopharma.com...

The same day, the company will hold a presentation of the quarterly results at the conference center of KS - Agenda , Haakon VII's gate 9 , Oslo 29. May 2015 at 08.30 hours. The presentation will be...